KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

BioNTech SE (BNTX) Research & Development: 2017-2024

Historic Research & Development for BioNTech SE (BNTX) over the last 8 years, with Dec 2024 value amounting to $2.4 billion.

  • BioNTech SE's Research & Development fell 9.25% to -$660.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.4 billion, marking a year-over-year decrease of 1.51%. This contributed to the annual value of $2.4 billion for FY2024, which is 25.56% up from last year.
  • According to the latest figures from FY2024, BioNTech SE's Research & Development is $2.4 billion, which was up 25.56% from $1.9 billion recorded in FY2023.
  • BioNTech SE's Research & Development's 5-year high stood at $2.4 billion during FY2024, with a 5-year trough of $769.0 million in FY2020.
  • In the last 3 years, BioNTech SE's Research & Development had a median value of $1.9 billion in 2023 and averaged $2.0 billion.
  • Data for BioNTech SE's Research & Development shows a peak YoY soared of 206.74% (in 2020) over the last 5 years.
  • Over the past 5 years, BioNTech SE's Research & Development (Yearly) stood at $769.0 million in 2020, then skyrocketed by 41.20% to $1.1 billion in 2021, then spiked by 44.41% to $1.6 billion in 2022, then rose by 22.34% to $1.9 billion in 2023, then grew by 25.56% to $2.4 billion in 2024.